Common Stock, Shares, Outstanding of Sonnet BioTherapeutics Holdings, Inc. from 31 Dec 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2010 to 30 Sep 2025.
  • Sonnet BioTherapeutics Holdings, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 7,077,352, a 988% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Sonnet BioTherapeutics Holdings, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 7,077,352 +6,427,068 +988% 30 Sep 2025 10-K 16 Dec 2025 2025 FY
Q2 2025 3,332,728 -1,885,777 -36% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q3
Q1 2025 3,123,429 +11,028 +0.35% 31 Mar 2025 10-Q 13 May 2025 2025 Q2
Q4 2024 3,007,431 -62,085 -2% 31 Dec 2024 10-Q 13 Feb 2025 2024 Q1
Q3 2024 650,284 +431,498 +197% 30 Sep 2024 10-K 16 Dec 2025 2025 FY
Q2 2024 5,218,505 -33,171,143 -86% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q3
Q1 2024 3,112,401 -17,385,969 -85% 31 Mar 2024 10-Q 14 May 2024 2024 Q2
Q4 2023 3,069,516 -4,894,525 -61% 31 Dec 2023 10-Q 14 Feb 2024 2024 Q1
Q3 2023 218,786 -33,169 -13% 30 Sep 2023 10-K 17 Dec 2024 2024 FY
Q2 2023 38,389,648 -22,198,257 -37% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q3
Q1 2023 20,498,370 -39,764,767 -66% 31 Mar 2023 10-Q 10 May 2023 2023 Q2
Q4 2022 7,964,041 -52,286,596 -87% 31 Dec 2022 10-Q 13 Feb 2023 2023 Q1
Q3 2022 251,955 -4,051,662 -94% 30 Sep 2022 10-K 14 Dec 2023 2023 FY
Q2 2022 60,587,905 +35,830,058 +145% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q3
Q1 2022 60,263,137 +39,065,847 +184% 31 Mar 2022 10-Q 10 May 2022 2022 Q2
Q4 2021 60,250,637 +43,074,908 +251% 31 Dec 2021 10-Q 08 Feb 2022 2022 Q1
Q3 2021 4,303,617 -10,420,488 -71% 30 Sep 2021 10-K 15 Dec 2022 2022 FY
Q2 2021 24,757,847 +15,557,671 +169% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q3
Q1 2021 21,197,290 +20,647,954 +3759% 31 Mar 2021 10-Q 17 May 2021 2021 Q2
Q4 2020 17,175,729 +16,775,562 +4192% 31 Dec 2020 10-Q 16 Feb 2021 2021 Q1
Q3 2020 14,724,105 +9,176,462 +165% 30 Sep 2020 10-K 17 Dec 2021 2021 FY
Q2 2020 9,200,176 +2,186,153 +31% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q3
Q1 2020 549,336 -3,182,450 -85% 31 Mar 2020 10-Q 18 May 2020 2020 Q1
Q4 2019 400,167 -3,315,277 -89% 31 Dec 2019 10-Q 18 May 2020 2020 Q1
Q3 2019 5,547,643 +1,841,080 +50% 30 Sep 2019 10-K 17 Dec 2020 2020 FY
Q2 2019 7,014,023 +3,314,753 +90% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 3,731,786 +509,577 +16% 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 3,715,444 +669,635 +22% 31 Dec 2018 10-K 19 Mar 2020 2019 FY
Q3 2018 3,706,563 +1,192,406 +47% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 3,699,270 +1,198,736 +48% 30 Jun 2018 10-Q 13 Aug 2018 2018 Q2
Q1 2018 3,222,209 -18,926,899 -85% 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 3,045,809 +906,385 +42% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2017 2,514,157 -19,442,990 -89% 30 Sep 2017 10-Q 13 Nov 2017 2017 Q3
Q2 2017 2,500,534 -19,456,613 -89% 30 Jun 2017 10-Q 14 Aug 2017 2017 Q2
Q1 2017 22,149,108 +811,861 +3.8% 31 Mar 2017 10-Q 15 May 2017 2017 Q1
Q4 2016 2,139,424 -19,197,823 -90% 31 Dec 2016 10-K 30 Mar 2018 2017 FY
Q3 2016 21,957,147 +628,317 +2.9% 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 21,957,147 +8,275,817 +60% 30 Jun 2016 10-Q 11 Aug 2016 2016 Q2
Q1 2016 21,337,247 +9,031,017 +73% 31 Mar 2016 10-Q 16 May 2016 2016 Q1
Q4 2015 21,337,247 +14,087,805 +194% 31 Dec 2015 10-K 31 Mar 2017 2016 FY
Q3 2015 21,328,830 +14,350,769 +206% 30 Sep 2015 10-Q 16 Nov 2015 2015 Q3
Q2 2015 13,681,330 +7,181,897 +110% 30 Jun 2015 10-Q 14 Aug 2015 2015 Q2
Q1 2015 12,306,230 +5,984,297 +95% 31 Mar 2015 10-Q 20 May 2015 2015 Q1
Q4 2014 7,249,442 +1,861,545 +35% 31 Dec 2014 10-K 31 Mar 2016 2015 FY
Q3 2014 6,978,061 +2,510,165 +56% 30 Sep 2014 10-Q 14 Nov 2014 2014 Q3
Q2 2014 6,499,433 +2,796,537 +76% 30 Jun 2014 10-Q 14 Aug 2014 2014 Q2
Q1 2014 6,321,933 +2,623,037 +71% 31 Mar 2014 10-Q 15 May 2014 2014 Q1
Q4 2013 5,387,897 +1,689,001 +46% 31 Dec 2013 10-K 15 Apr 2015 2014 FY
Q3 2013 4,467,896 +769,000 +21% 30 Sep 2013 10-Q 15 Nov 2013 2013 Q3
Q2 2013 3,702,896 +4,000 +0.11% 30 Jun 2013 10-Q 12 Aug 2013 2013 Q2
Q1 2013 3,698,896 +1,200,005 +48% 31 Mar 2013 10-Q 15 May 2013 2013 Q1
Q4 2012 3,698,896 +2,449,450 +196% 31 Dec 2012 10-K 31 Mar 2014 2013 FY
Q3 2012 3,698,896 +1,200,172 +48% 30 Sep 2012 10-Q/A 31 Dec 2012 2012 Q3
Q2 2012 3,698,896 +1,237,922 +50% 30 Jun 2012 10-Q/A 02 Jan 2013 2012 Q2
Q1 2012 2,498,891 31 Mar 2012 10-Q/A 28 Dec 2012 2012 Q1
Q4 2011 1,249,446 -799,242 -39% 31 Dec 2011 10-K 03 Apr 2013 2012 FY
Q3 2011 2,498,724 30 Sep 2011 10-Q 14 Nov 2011 2011 Q3
Q2 2011 2,460,974 30 Jun 2011 10-Q 15 Aug 2011 2011 Q2
Q4 2010 2,048,688 31 Dec 2010 10-K/A 28 Dec 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.